Toronto-based Canaccord Financial Inc. (TSX: CF) said Tuesday that Steve Buell has been appointed global head of research at Canaccord Genuity, where he will oversee the company’s comprehensive research offering.
With research published from four regions Canaccord Genuity provides a global perspective on investing opportunities, and Buell will be entrusted with developing strategies to ensure clients benefit from the full scope of Canaccord’s research, and implementing best practices across the company’s global platform.
Buell joined Canaccord Genuity in 2010 as managing director and director of U.S. equity research. Prior to this, he served as global head of equity research at Piper Jaffray, Thomas Weisel Partners, Prudential Equity Group and ING Barings. He has over 25 years of industry experience and holds a PhD in Neuroscience from the University of Rochester, School of Medicine and a BA in Biology from the University of Colorado.
Along with his new role, Buell will continue as director of U.S. research for Canaccord Genuity and will be based out of the company’s New York office.
“Steve Buell has world-class experience in leading and overseeing expansive research teams, and we’re confident we can draw on his expertise to further develop the ways we provide our investment insights to our institutional and retail clients,” said Paul Reynolds, president and CEO of Canaccord Financial Inc.
This announcement is the latest of several management appointments aimed at strengthening the global integration of Canaccord Genuity’s capital markets team. In October, Phil Evershed was appointed global head of investment banking. In September, Peter O’Malley joined as CEO of Canaccord Genuity Asia to oversee Canaccord operations in mainland China, Hong Kong and Singapore, and Alexis de Rosnay joined as CEO of Canaccord’s U.K. and Europe operations.